Management of kidney cancer relapse to adjuvant pembrolizumab: Early insights and questions for a newly emerging space Editorial

  

Authors:	Voss, M. H.; Motzer, R. J.
Title:	Management of kidney cancer relapse to adjuvant pembrolizumab: Early insights and questions for a newly emerging space
Keywords:	controlled study; overall survival; cancer recurrence; drug efficacy; adjuvant therapy; cancer adjuvant therapy; follow up; progression free survival; editorial; renal cell carcinoma; protein tyrosine kinase inhibitor; kidney cancer; drug therapy; cytotoxic t lymphocyte antigen 4; programmed death 1 ligand 1; programmed death 1 receptor; human; pembrolizumab
Journal Title:	European Urology
Volume:	86
Issue:	6
ISSN:	0302-2838
Publisher:	Elsevier Science, Inc.
Date Published:	2024-12-01
Start Page:	513
End Page:	515
Language:	English
DOI:	10.1016/j.eururo.2024.09.018
PUBMED:	39317631
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85204803057&doi=10.1016%2fj.eururo.2024.09.018&partnerID=40&md5=e2cef9a2277f160ae2739ee0db4499ac
Notes:	Editorial -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/221311